Please login to the form below

Not currently logged in
Email:
Password:

KCL appoints Luigi Martini as first chair of pharmaceutical innovation

Rainbow Medical Engineering director to lead new discoveries and inventions at King’s College London

Prof Luigi Gino Martini - King's College LondonKing's College London has appointed Rainbow Medical Engineering director Professor Luigi Martini as its first Chair of Pharmaceutical Innovation.

The newly-created position will see Martini work in the college's Institute of Pharmaceutical Science to strengthen its ability to ensure new discoveries and inventions across King's Health Partners are transferred to clinical and pharmaceutical development.

King's Health Partners is one of the UK's five academic health sciences centres, organisations that provide health care to patients and undertake health-related research. It combines the King's College London university and three NHS Foundation Trusts of Guy's and St Thomas', King's College Hospital and South London and Maudsley.

Prior to his role at Rainbow Medical, Martini was senior director of preclinical and pharmaceutical development for Emerging Markets and Asia Pacific at GlaxoSmithKline.

He is also a Fellow of the Royal Pharmaceutical Society of Great Britain, with research interests including the design of dosage form concepts for delivering personalised medicines and the development of biopharmaceuticals.

On his appointment, Martini said: “I am honoured to be joining this first-class institution, particularly in a role - the first of its kind in the UK - that demonstrates King's visionary leadership and ambition.”

6th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics